Searched for
FDA REGULATIONS
Dabur India shares in focus after US FDA places drugs from Silvassa plant under import alert. Here’s whyDabur India shares are set to be in focus after the US FDA issued an import alert on drugs manufactured at its Silvassa plant, citing data ...- US drug regulator issues import alert for drugs made at a Dabur India plantThe US Food and Drug Administration has placed Dabur India's factory on an import alert. This action follows an inspection that revealed si...
- Govt outlines next phase of pharma growthThe government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...
- Trump tariffs changed taste of foods in U.S? Label checking reveals shocking detailsTrump Tariffs have grabbed headlines and become the topic of discussion around the world. Now there is a reality-check on the food ingredie...
- US stocks: Fulcrum shares plummet over 50% after scrapping lead sickle-cell drug on FDA concernsThe oral drug, pociredir, was being tested to treat sickle-cell disease, an inherited blood disorder that can trigger pain, anemia and or...
- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Wockhardt secures US FDA approval for antibiotic ZaynichWockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract infections. Thi...
- U.S. drug regulator flags data integrity, maintenance lapses at Dabur India plantThe U.S. FDA has identified significant data integrity and manufacturing lapses at a Dabur India plant following a January inspection. Find...
- Tata Elxsi unveils AnaTel, an AI-powered platform for healthcare software engineering and regulatory complianceTata Elxsi’s AnaTel reflects the growing shift toward AI-native healthcare software engineering, bringing AI-driven automation into regulat...
- Experts back OTC access to NRT across all formats and dosages, including 2 mg and 4 mg, as India struggles with a Tobacco quit success rate under 5%The report highlights the significant economic burden of tobacco use, particularly among low-income households, and underscores how reducin...
- Multiple items recalled at Walmart, ALDI including frozen pizza and pork rinds amid salmonella concerns - Check the contaminated ingredient and full list of productsA nationwide recall has been issued for at least eight products sold at ALDI and Walmart , including frozen pizzas and pork rinds, due to p...
- What is mifepristone, and why is it used? Court restricts abortion access by blocking mailing of abortion pill in USWhat is mifepristone, and why is it used? A federal appeals court has restricted access to mifepristone by blocking mailing of prescription...
- Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
- India-New Zealand FTA to be signed on Monday, says PM Christopher LuxonIndia and New Zealand will sign a Free Trade Agreement on Monday, April 27. This landmark deal aims to boost bilateral trade significantly....
- Has Donald Trump administration made Marijuana legal for medical or recreational use in U.S.? Shares of cannabis firms jump big in U.S. Stock MarketCannabis decision by the Federal Government Iargely legitimizes medical marijuana programs in the 40 states that have adopted them.
- Social media is abuzz with weight-loss drug retatrutide and longevity goals. What is the drug all about?A new weight-loss drug, retatrutide, is generating excitement. This investigational medicine targets three hormone receptors, offering a po...
- Drugmaker Granules to tighten oversight after US FDA warning, executive saysThe company, which is globally one of the largest paracetamol makers and a major player in the active pharmaceutical ingredients market, de...
- Indian drugmaker Granules to tighten oversight after US FDA warning, exec saysAmid growing scrutiny from the U.S. FDA over documentation practices and contamination issues, Granules India is reinforcing its manufactur...
- Did Ozempic manufacturer Novo Nordisk hide drug death reports? Here’s what FDA said about side-effect reportingDespite ongoing debate, medications such as Ozempic continue to rank among the most commonly prescribed treatments for weight management an...
Load More
